RegIntel

RegIntel™ by Lexim AI is a global regulatory intelligence platform purpose-built for life sciences professionals. Powered by artificial intelligence, it unifies regulatory research, AI-driven analysis, and automated workflows into a single hub, enabling medical device manufacturers, pharmaceutical teams, and regulatory consultants to stay compliant, reduce risk, and accelerate market access — delivering regulatory clarity in minutes rather than months.

Designed to eliminate fragmented tools and manual document searching, RegIntel™ provides a centralized, always-updated source of regulatory truth. Teams benefit from improved alignment, standardized requirement interpretation, and data-backed decision-making confidence across global markets.

Immediate, Measurable Impact

• Save hundreds of hours per year by eliminating manual document searching and interpretation
• Improve team alignment with a centralized, shared regulatory source of truth
• Standardize requirement interpretation to enhance consistency and quality across teams
• Reduce compliance risk with always-updated regulatory intelligence
• Shorten global market entry timelines through faster requirement analysis and submissions preparation
• Boost decision-making confidence with data-backed insights rather than assumptions

Global Regulatory Coverage

• Access regulations, standards, and guidance from over 80 countries through one unified, always-up-to-date platform
• Content sourced directly from leading regulatory bodies, reducing the need for manual searches
• One centralized regulatory intelligence hub that eliminates fragmented tools and aligns teams around a single source of truth

AI Agents and Workflow Automation

• Offload document reviews, comparisons, and summaries to AI agents, automating repetitive regulatory work
• Generate structured outputs that reduce manual effort and review cycles, accelerating submissions preparation
• Scale regulatory capacity instantly — increase throughput without adding headcount

Smart Document Interaction

• Communicate directly within regulatory documents to instantly surface relevant sections without scrolling through hundreds of pages
• Side-by-side market comparisons to align global strategies faster by comparing requirements across regions
• Visualize regulatory differences to quickly identify overlaps, gaps, and divergences that impact compliance

Real-Time Data Insights

• Leverage millions of global regulatory data points to inform strategic decisions
• Track regulatory changes, approvals, and trends as they happen with live updates
• Replace assumptions with insight-backed planning and execution for a data-driven regulatory strategy

Capabilities for Medical Device Manufacturers

• AI-driven overview of global device regulations and market-entry requirements to streamline design control and expedite submissions
• Access to MDR, IVDR, FDA guidance, and global standards
• AI-supported reviews of safety and performance requirements
• Faster preparation for audits and documentation, reducing complexity across markets and product families

Capabilities for Pharmaceutical Teams

• Centralized access to global pharmaceutical regulations covering GxP, clinical, and labeling requirements
• Faster interpretation of GCP, GMP, GLP, and submission guidelines
• Predictive insights for global filings
• Accelerated launch preparation across international markets

Capabilities for Regulatory Consultants

• AI-assisted research to speed up project kickoffs, compliance assessments, gap analyses, and multi-market strategy development
• Custom outputs for market assessments and regulatory plans
• Enhanced accuracy and consistency across client deliverables
• Support for higher-value, insight-driven regulatory services that help advisory firms scale efficiently

RegIntel™ is designed to serve the full spectrum of life sciences organizations — from medical device manufacturers navigating complex global standards to pharmaceutical teams managing multi-market filings and consulting firms delivering client-facing regulatory strategies. A demo is available to explore the platform's capabilities firsthand.